-+ 0.00%
-+ 0.00%
-+ 0.00%

Salesforce, AbbVie, Intuitive Surgical And An Industrial Stock On CNBC's 'Final Trades'

Benzinga·04/23/2025 12:36:38
Listen to the news

On CNBC's “Halftime Report Final Trades,” Joshua Brown, CEO and co-founder, Ritholtz Wealth Management, said he is staying long on 3M Company (NYSE:MMM).

Supporting his view, 3M reported better-than-expected first-quarter financial results on Tuesday. The company reported net sales of $5.95 billion, a 1.0% decline year-over-year (Y/Y), beating the consensus of $ 5.78 billion. Adjusted EPS was $1.88, up 10% Y/Y, beating the consensus of $1.77.

Jim Lebenthal of Cerity Partners picked AbbVie Inc. (NYSE:ABBV) as his final trade.

Lending support to his choice, Cantor Fitzgerald analyst Carter Gould initiated coverage of AbbVie on Tuesday with an Overweight rating and a price target of $210.

Don't forget to check out our premarket coverage here

Rob Sechan of New Edge Capital Group named Salesforce, Inc. (NYSE:CRM) as his final trade.

Guggenheim analyst John Difucci upgraded Salesforce from Sell to Neutral on Monday.

Stephanie Link of Hightower picked Intuitive Surgical, Inc. (NASDAQ:ISRG) as her final trade.

On the earnings front, Intuitive Surgical reported first-quarter revenue of $2.25 billion on Tuesday, beating analyst estimates of $2.19 billion. The robotic-assisted surgery company reported first-quarter adjusted earnings of $1.81 per share, beating analyst estimates of $1.72 per share.

Price Action:

  • 3M shares jumped 8.1% to close at $136.33 on Tuesday.
  • AbbVie gained 2.1% to close at $173.78 during Tuesday's session.
  • Salesforce shares rose 3% to close at $243.39 on Tuesday.
  • Intuitive Surgical shares climbed 2.2% to settle at $478.74 during the session.

Check This Out:

Photo: Shutterstock